Abortion Rights

22 Sep

Reproductive Health Care Post-Roe (2025-2026)

RileyLatest News, , , , ,
Duke University Hospital’s unique geography (North Carolina is the furthest southern state now permitting abortion care), along with its institutional structure (private rather than public), make it an ideal place to examine access to reproductive healthcare. This project documented the medical, ethical and political conditions of the post-Roe landscape as seen from the viewpoints and experiences of reproductive care providers.
Read More
18 Sep

Guttmacher Institute Announces 2026–2029 Strategic Plan to Meet Urgent Challenges Facing Sexual and Reproductive Health and Rights

MorganLatest News, , , , ,
The Guttmacher Institute today announced its 2026–2029 Strategic Plan, a focused roadmap for strengthening the Institute’s role as a trusted source of evidence and action at a time of profound threats to sexual and reproductive health and rights (SRHR) in the United States and around the world.
Read More
12 Sep

Virginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access

ChaseLatest News, , , , ,
A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS).
Read More
10 Sep

In wide-ranging amicus briefs, experts again urge the Fifth Circuit to reject restrictions on telehealth access to mifepristone

ChaseLatest News, , , , , ,
Ahead of oral argument in Louisiana v. U.S. Food and Drug Administration (FDA) on September 9, a wide range of experts — including the American College of Obstetricians and Gynecologists, American College of Emergency Physicians, the National Domestic Violence Hotline, the Disability Rights Education & Defense Fund, the NAACP Legal Defense & Educational Fund, pharmaceutical and biotech manufacturers, and former military officials — are urging the U.S. Court of Appeals for the Fifth Circuit to reject anti-abortion politicians’ effort to end telemedicine and mail and pharmacy access to mifepristone nationwide.Mifepristone is used in nearly two-thirds of U.S. abortions, with more than 1 in 4 patients
Read More
31 Aug

New Battleground Poll: Todd Blanche’s Anti-Abortion Record is Toxic for Congressional Republicans Ahead of Critical Midterms

DoryLatest News, , , , , , , ,
New battleground polling conducted by Reproductive Freedom for All and Public Policy Polling shows that Todd Blanche’s threats to use the Department of Justice (DOJ) to restrict abortion access are deeply unpopular and could create serious political consequences for congressional Republicans in November.
Read More
19 Aug

Reproductive Freedom for All Condemns Senate Confirmation of Erica Schwartz as CDC Director

PhoenixLatest News, , , ,
The U.S. Senate confirmed Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC), despite her dangerous commitment to undermine abortion access and patients’ data privacy. During her confirmation hearing, Schwartz said abortion surveillance is “absolutely a critical component” of the CDC’s work and signaled the federal government could explore collecting more sensitive abortion data. 
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.